Recall Record

Rochester, NY, United States

Ortho-Clinical Diagnostics, Inc. recalls

70 recalls recorded since 2018, most recently on 29 July 2025. 41 are listed as ongoing. Status and classification are as published by the FDA.

Recalls70
Ongoing (FDA)41
Terminated or completed29
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
29 July 2025
Reason
VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above with Condition Code TH4-63J during calibration, causing the delay of lac test results and potentially impact patient management. The issue was identified by QuidelOrtho through an increase in customer complaints compared to the historical baseline with average failure rate of 1% for coating 0130 in 2025 while average of failure rate for other coating was 0.06% in 2025 and average of failure rate for all coatings is 0.03% for 2024.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2560-2025, Z-2559-2025

Ongoing Class II Medical devices

Recall started
9 July 2025
Reason
Generations 67 and above of VITROS Ca Slides are experiencing an increased occurrence of Condition Code TH4-63J during calibration on VITROS XT 3400 and VITROS XT 7600 Systems, causing calibration failures that delay calcium test results and potentially impact patient management. The imaging reflectometer algorithm detects excessive "spikes" (imperfections) in slide images and generates the TH4-63J condition code when the threshold of 600 spikes is exceeded. Updated analysis revealed a 19-fold increase in failure rates from 0.0043% (2024 baseline) to 0.082% for Generation 67+ slides in 2025, with 100% of calibrator failures occurring at the lowest concentration level. This can result in delayed diagnosis and treatment of conditions such as hypercalcemic crisis, parathyroid disorders, and other calcium-related emergencies requiring urgent intervention.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Spain, Sweden, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2335-2025

Ongoing Class II Medical devices

Recall started
12 June 2025
Reason
Lots from Generation (GEN) 15 of VITROS Chemistry Products OP Reagent may generate lower than expected quality control (QC) results. If the customer is unable to get passing quality control results, then the customer would be unable to run the OP-LO protocol leading to a potential delay in patient results.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, France, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2073-2025

Ongoing Class II Medical devices

Recall started
10 June 2025
Reason
Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7 days after reconstitution; however, the label stability claims for the PV fluids is 7 days following reconstitution. This may lead to inaccurate QC results. The use of the PVs when the QC results are outside of the customer s established ranges could result in delayed results for patients due to the need to repeat QC testing or reconstitute new PV fluids and repeat testing. It could also result in erroneous patient results (small positive bias).
Distribution
Worldwide Distribution: US (nationwide) to states of: AZ, CA, FL, GA, IL, MD, MI, MO, MS, NY, TN, TX, VA; and OUS (International) to countries of: Australia, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapor
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2120-2025, Z-2121-2025, Z-2122-2025, Z-2123-2025

Ongoing Class II Medical devices

Recall started
9 May 2025
Reason
a software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the Use Expired Reagents setting is not enabled if a shelf expiration date is omitted during manual loading. The issue was identified by a customer complaint, in which a CREA Urine test was processed with an RE (Reagent Expired) code, even though the diluent pack was not expired and the use-expired-reagents setting was disabled. This can result in erroneous test results and/or delaying test results.
Distribution
Worldwide Distribution: US (Nationwide) and OUS (International) to countries of: Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Spain, Sweden, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2039-2025, Z-2040-2025, Z-2038-2025

Ongoing Class II Medical devices

Recall started
14 April 2025
Reason
Product was incorrectly assigned GEN 88 instead of GEN 83 on product carton, foil wrapper, and cartridge (cart) label.
Distribution
Worldwide - US Nationwide distribution in the states of AR, AZ, CO, FL, GA, ID, IL, IN, KS, MI, MN, MO, MS, MT, ND, NE, NH, NJ, NY, OH, OK, PA, SC, TN, TX, VA, WI, WV & WY and the countries of Canada, Chile, Colombia, France, India, Italy, Mexico & Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-1876-2025

Ongoing Class II Medical devices

Recall started
24 March 2025
Reason
It was determined that there could be a false positive rate of up to 16.7% for the affected lots associated with the Bordetella parapertussis (BPP) results (only) of the assay.
Distribution
Please see the attached list "Consignee List_CL2025-120." Note: This file contains a specific tab, titled Shipping Summary, which contains the US and ex-US shipping summary. One (1) Distributor was affected. The other four(4) Distributors were sent the notification for information only. Quide
Initiated
Voluntary: Firm initiated
Recall number
Z-1948-2025

Ongoing Class II Medical devices

Recall started
19 December 2024
Reason
The VITROS XT 7600 Integrated System software versions 3.8.0 may not correctly notify users if the Signal Reagent Pack exceeds the on-board and/or shelf-life expiration date. This could result in the use of expired products, which would increase the risk of no results or erroneous results from the instrument.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Spain, Sweden, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1006-2025, Z-1005-2025, Z-1007-2025

Ongoing Class II Medical devices

Recall started
11 October 2024
Reason
May Generate Negatively Biased Results When Testing Samples with High Concentrations of CRP, showing less than upper AMI of 90 mg/L (in the 70-90 mg/L range) while the samples having higher than 90 mg/L. User no way to know if the sample has to be diluted to measure again.
Distribution
Worldwide - US Nationwide distribution in the states of AZ, FL, ID, IL, KS, MN, MT, NY, PA, UT and the countries of Australia, Belgium, Bermuda, Brazil, Canada L3R 0B8, Chile, China, Colombia, Denmark, France, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore 609917,
Initiated
Voluntary: Firm initiated
Recall number
Z-0535-2025

Ongoing Class II Medical devices

Recall started
10 July 2024
Reason
The reason for this recall is QuidelOrtho has determined that during normal use the VITROS XT ALB-TP Slides may shed dust and debris as they travel through the MicroSlide Subsystem of the VITROS XT 3400 or VITROS XT 7600 analyzer. This dust and debris may then settle onto VITROS Na+ (Sodium) Slides as they are processed through the same MicroSlide Subsystem, potentially resulting in an increase in non-reproducible, positively, or negatively biased Na+ results. The level of bias will depend on where the dust and debris settle on the Na+ MicroSlide and may impact Na+ measurements to varying degrees inside and outside of the measuring range depending on the amount of contamination. All of which could vary from no/low bias with no patient harm, to extreme bias (falsely elevated or reduced results) potentially resulting in incorrect diagnosis; treatment; and/or a serious patient health hazard (for example, hypernatremia or hyponatremia). This issue may also potentially generate error codes preventing the analyzer from processing the MicroSlide Assays and cause delay of the patient results. All current and expired VITROS XT Chemistry Products ALB-TP slides are affected by this issue.
Distribution
Nationwide. Foreign: Australia Belgium Bermuda Brazil Canada L3R 0B8 Chile China Colombia Denmark France Germany India Italy Japan Mexico Norway Portugal Russia Singapore 609917 Spain Sweden The Netherlands United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-2684-2024

Ongoing Class II Medical devices

Recall started
3 July 2024
Reason
It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the increase in "TM5-4MB" condition codes which lead to a delay of results.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Sweden, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2580-2024

Ongoing Class II Medical devices

Recall started
21 May 2024
Reason
VITROS Chemistry Products FS Diluent Pack 3, Lot 01-1645 may cause results to be negatively biased when used to dilute patient samples tested with VITROS Chemistry Products CRP Slides.
Distribution
Worldwide - US Nationwide distribution in the states of FL, IL, NY, PA and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Spain, Singapore, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2266-2024

Ongoing Class III Medical devices

Recall started
14 May 2024
Reason
Kit assigned an extended expiration date of 24-Jul-2025 during release. The correct expiration date for Lot 2953 is 24-Jul-2024. If used past its true expiration and the customer does not have their Assay Data Disk (ADD) updated, the system will allow them to use the expired calibrator which may bias the results. However, at this time the calibrator is within its use date and will function appropriately.
Distribution
Worldwide distribution - US Nationwide including Puerto Rico and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2245-2024

Ongoing Class III Medical devices

Recall started
8 May 2024
Reason
The results generated by the VITROS Immunodiagnostic Products Vitamin B12 Range Verifier Lot# 1200 RV Level 2 may cause range verification failure. The issue is detectable by the user when the product fails to meet the required range during processing of RV Level 2 of this lot. There is a potential for a delay in patient test results should the user have a need to switch to an alternate method of range verification including use of an alternate lot. As this issue affects the upper limit range verification, there is no impact to VITROS Immunodiagnostic Products Vitamin B12 assay performance. Were the assay to not perform as expected, the failure would be detectable by Quality Control. Past patient sample results are unaffected, and no review of reported results is required.
Distribution
Worldwide - US Nationwide and the country of Columbia.
Initiated
Voluntary: Firm initiated
Recall number
Z-2019-2024

Ongoing Class II Medical devices

Recall started
1 March 2024
Reason
Potential for positively biased results due to signal reduction over shelf life.
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MI, MT, NC, NJ, NY, OH, OK, OR, PA, SC, SD, TN, TX, VA, VT, WI, WV and the countries of Bermuda, Colombia, Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-2142-2024

Ongoing Class II Medical devices

Recall started
27 February 2024
Reason
The issue was mismatched diluent lots assembled into VITRO Chemistry Products Performance Verifier I and II. This issue has the potential to cause erroneous Quality Control (QC) results that could lead to testing delays and erroneous patient results. This issue caused positive or negative bias in the quantification of sodium (Na+) and total carbon dioxide (ECO2). The incorrect diluent into the Performance Verifier II exhibited a potential negative bias of up to 6 mmol/L for ECO2 and Na+ testing.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1372-2024, Z-1373-2024

Ongoing Class II Medical devices

Recall started
26 January 2024
Reason
A software defect affecting VITROS Systems running VITROS Software Versions 3.8.1 causes QC baseline statistics to not update as expected when changed by the user. This may cause erroneous patient results to be reported.
Distribution
Worldwide - US Nationwide distribution in the states of AZ, CA, CT, FL, IA, ID, IL, IN, KY, LA, MO, NE, NY, OH, OR, SC, SD, TX, WA, WI, WV and the countries of Australia, Brazil, Canada, China, Colombia, India, Mexico, Singapore, United Kingdom, Italy, Spain, Russia, France, and Belgium.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1226-2024, Z-1228-2024, Z-1227-2024, Z-1224-2024, Z-1225-2024

Ongoing Class II Medical devices

Recall started
26 January 2024
Reason
A software defect affecting VITROS Systems running VITROS Software Versions 3.8.0 and 3.8.1 causes the Configurable Westgard Rules to not report as expected. When a new control is defined, configurable Westgard rules, if selected, are not flagged or reported with the applicable QC results if the statistical criteria is met. This may result in acceptance of QC results that do not meet acceptance criteria, which may cause erroneous patient results to be reported.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1233-2024, Z-1230-2024, Z-1231-2024, Z-1229-2024, Z-1232-2024

Ongoing Class II Medical devices

Recall started
22 January 2024
Reason
Potential For Aspiration from Unintended Sample Container During Sampling Center Processing on VITROS¿ 3600 Immunodiagnostic Systems and VITROS¿ 5600/XT 7600 Integrated Systems which may lead to erroneous test results.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Spain, Sweden, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1221-2024, Z-1222-2024, Z-1220-2024

Ongoing Class II Medical devices

Recall started
27 November 2023
Reason
Affected lots may experience increased calibration failures or an increase in falsely elevated results.
Distribution
Domestic distribution nationwide. OUS distribution to Bermuda, Australia, Brazil, Canada, Chile, China, Columbia, India, Japan, Mexico, Singapore, UK, France, Germany, Italy, Spain, Portugal, Russia, Denmark, Norway, Sweden, France, Belgium, and The Netherlands.
Initiated
Voluntary: Firm initiated
Recall number
Z-0772-2024

Ongoing Class II Medical devices

Recall started
21 November 2023
Reason
Ortho-Clinical Diagnostics, Inc. is recalling QMS Tacrolimus Calibrators, Lot 74859619 expiry date: May 11, 2024, due to improper storage that is expected to degrade the quality of the calibrator and render it unsuitable for use. Use of the affected lot may results in erroneous calibration results, causing delay in testing.
Distribution
Domestic distribution to IL, IN, FL, NJ, NM, TX. International distribution to Chile.
Initiated
Voluntary: Firm initiated
Recall number
Z-0712-2024

Ongoing Class II Medical devices

Recall started
25 October 2023
Reason
Ortho Clinical Diagnostics (QuidelOrtho) confirmed during routine testing that some lots from Coating 3598 of VITROS ECO2 slides included carts which may contain consecutive slides that may not function as intended. These affected slides (potentially intermittent, consecutive slides within a cart or across consecutive carts) have an abnormality which may cause positively or negatively biased total carbon dioxide (CO2) results leading to either overdiagnosis of acidosis or missing alkalosis, both which may prompt unnecessary therapies such as IV fluids and/or bicarbonate or overdiagnosis of alkalosis which may also result in unnecessary use of IV fluids and electrolyte replacement or failure to detect acidosis and necessary treatment.
Distribution
Nationwide Foreign: Bermuda Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-0510-2024

Ongoing Class II Medical devices

Recall started
10 October 2023
Reason
During planned monitoring of data post-release of Software Version 3.8.0 an increased occurrence of software issues relating to unresponsive subsystems, unresponsive user interface (sometimes referred to as a screen freeze), and/or printer disconnections was identified. The consequence of these issues would be a delay in reporting results due to the required system shutdowns to recover the system. This delay in reporting results could occur during any assay, including which the speed of the result is deemed critical or STAT and could result in a delay of treatment in a patient. Due to the release strategy of this software version, the user could not update the system but a field engineer had to manually install each affected system.
Distribution
US Nationwide. Global Distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0546-2024, Z-0544-2024, Z-0547-2024, Z-0545-2024, Z-0543-2024

Ongoing Class II Medical devices

Recall started
12 September 2023
Reason
Products 1668409 and 8297749 may contain VITROS Lipase Slides with an abnormality which could cause -46% to +86% bias in lipase results depending on how the slides are used. Falsely low levels could result in a missed or delayed diagnosis of acute pancreatitis and may lead to diagnostic confusion in the setting of acute abdominal symptoms. Falsely elevated levels would not result in patient harm but may cause diagnostic confusion and a delay in accurate diagnosis of a patient with abdominal pain.
Distribution
US States: CA, CO, FL, GA, IL, IN, KS, NC, NY, TN, TX, VT. Canada, France, India, Japan, South Korea
Initiated
Voluntary: Firm initiated
Recall number
Z-0236-2024

Ongoing Class II Medical devices

Recall started
9 August 2023
Reason
Ortho Clinical Diagnostics (QuidelOrtho) confirmed certain Proboscis/Piston Assemblies manufactured between 07-Apr-2022 (Date code: 040722) and 19-Dec-2022 (Date code: 121922) may not perform as intended due to an out-of-specification barrel component. This may cause VITROS VersaTips and/or VITROS MicroTips to be improperly seated on the proboscis, which may result in falsely elevated Gentamicin and Valproic Acid assay results as well as an increased frequency of condition codes resulting in delayed patient results. The issue was identified by internal testing when reported instruments failed to pass release testing and were traced to the molded Proboscis part J56639 with date codes from 040722 onward.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0008-2024

Ongoing Class II Medical devices

Recall started
5 August 2023
Reason
Samples containing high levels of ALKP (or an interfering substance) could deplete the available substrate in the reagent layer of a VITROS ALKP Slide and not post the substrate deleption (DP) code, which may result in the System reporting an incorrect value (lower than the actual value), which may result in missed or delayed diagnosis of liver disease.
Distribution
Worldwide Distribution: US (nationwide) and OUS (foreign) distribution to countries of: Bermuda, Belgium, Australia, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, Italy, India, Japan, Mexico, Netherlands, Norway, Singapore, Spain, Sweden, Portugal, Russia, United Kingdom
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2624-2023, Z-2623-2023

Ongoing Class II Medical devices

Recall started
5 June 2023
Reason
Reagent packs could potentially contain incorrect wells, which will generate incorrect, and potentially false negative, results.
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2357-2023, Z-2358-2023

Ongoing Class III Medical devices

Recall started
18 May 2023
Reason
May not meet the stability specifications for shelf life outlined in the Instructions For Use (IFU).
Distribution
US Nationwide distribution in the state of CA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2225-2023

Ongoing Class II Medical devices

Recall started
8 May 2023
Reason
Potential to cause biased results in the upper end of the reportable range for the quantitative measurement of Transferrin, C3, C4, IgA, IgG and IgM. Within the reference interval, the highest bias observed in selected sample testing investigation was +35.3% for IgM; -4.3% for IgG; +12.3% for IgA; -6.9% for C3; -6.6% for C4; and -17.8% for transferrin. Falsely elevated or reduced results could be reported depending on the analyte and/or sample concentration.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada L3R 4G5, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore 609917, Spain, Sweden , The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2129-2023

Ongoing Class II Medical devices

Recall started
17 April 2023
Reason
Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis
Distribution
US Nationwide- Worldwide Distribution. Foreign: Australia Belgium Brazil Bermuda HM12 Canada L3R 4G5 Chile China Colombia Denmark France France Germany India Italy Japan Mexico Norway Portugal Russia Singapore 609917 Spain Sweden The Netherlands United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-1628-2023

Ongoing Class II Medical devices

Recall started
14 April 2023
Reason
Unavailable to calibrate VITROS Chemistry Products VANC Reagent, Generation (GEN) 50, results in delay of testing
Distribution
Nationwide Foreign: Brazil, Chile, Colombia
Initiated
Voluntary: Firm initiated
Recall number
Z-1664-2023

Ongoing Class II Medical devices

Recall started
10 March 2023
Reason
MicroTip Pack Opener Assembly Potentially Not Removing or Replacing MicroTip Pack Caps on VITROS¿ 5600 and XT 7600 Integrated Systems, results may be delayed results if a pack becomes unusable
Distribution
Nationwide including Puerto Rico and Bermuda Foreign: Australia Belgium Brazil Canada Chile China Colombia Denmark France Germany India Italy Japan Mexico Norway Portugal Russia Singapore Spain Sweden The Netherlands United Kingdom
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1556-2023, Z-1555-2023, Z-1557-2023

Ongoing Class II Medical devices

Recall started
9 March 2023
Reason
Incorrect Number of Calibrator Levels (2) Set for the VITROS Immunodiagnostics Products Anti-SARS-CoV-2 Total N Antibody Calibrators in Assay Data Disks (ADD), resulting in delayed patients results
Distribution
US Nationwide distribution in the states of AL, AZ, CA, GA, NY.
Initiated
Voluntary: Firm initiated
Recall number
Z-1396-2023

Ongoing Class II Medical devices

Recall started
17 November 2022
Reason
Lower than expected iPTH patient and Quality Control (QC) results, reported negatively biased iPTH results- an average -12% shift in patient sample results
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda DV04, Bermuda HM12, Brazil, Canada L3R 4G5, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-0878-2023

Ongoing Class II Medical devices

Recall started
13 October 2022
Reason
Calibration disk Data Release Version (DRV) 6194 to 6200 contain inappropriate calibration mathematics for VITROS Calibration Kit 9 for calibrating VITROS PHYT Slides, for all lots of slide generation 22 (GEN 22). The erroneous mathematics on the calibration disk prevents the VITROS 250/350 Chemistry System from successfully calibrating, leading to delayed results.
Distribution
Worldwide Distribution: US (Nationwide) and Countries (Foreign) including: Australia Bermuda DV04 Bermuda, HM 13 Bermuda, HM08 Brazil Canada L3R 4G5 Chile China Colombia Denmark France Germany India Italy Japan Mexico Norway Portugal Russia Singapore 609917 Spain Sweden United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-0220-2023

Ongoing Class II Medical devices

Recall started
19 July 2022
Reason
Performing a system shutdown on VITROS XT 3400 and VITROS XT 7600 Systems may cause a positive or negative shift in the electrical current supplied to the LED used in conjunction with the Digital Imaging Reflectometer. Potential exists for either a positive or negative shift in results reported by the VITROS System.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda DV04, Brazil, Canada L3R 4G5 , Chile, China, Colombia, Denmark, France, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore 609917, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1676-2022, Z-1675-2022

Ongoing Class II Medical devices

Recall started
26 May 2022
Reason
On-Analyzer Stability (OAS) time, supported for 6 weeks; not 8 weeks as is currently stated in the Instructions For Use (IFU).
Distribution
Worldwide distribution - US Nationwide and the countries of Colombia, India, Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-1367-2022

Ongoing Class II Medical devices

Recall started
25 March 2022
Reason
Falsely high or delayed patient and QC results may occur due to low end imprecision. VITROS Immunodiagnostic Products FSH, LH and Prol Reagents Low End Imprecision. Low-level quality control (QC) and patient samples at the low end of the Measuring (Reportable) Range when using VITROS FSH, LH and Prol Reagent. Calibration failures, driven by imprecision observed with Calibrator Level 1.
Distribution
Worldwide Distribution: US (Nationwide) OUS (Foreign): Australia Bermuda Brazil Canada L3R 4G5 Chile China Colombia Denmark France Germany India Italy Japan Mexico Netherlands Norway Portugal Russia Singapore Spain Sweden United Kingdom
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1113-2022, Z-1112-2022, Z-1114-2022

Ongoing Class II Medical devices

Recall started
10 December 2021
Reason
The lot has a shape deformity which may lead to a 16% reduction in the volume of the sample or reagent dispensed. In cases where the error is not detected and the affected results are not suppressed, clinical impact may include reduced drug dosage, or false positive or false negative results for bloodborne infectious disease assays when sample results are close to the cut-off value.
Distribution
Domestic distribution nationwide. Foreign distribution to Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0735-2022

Ongoing Class II Medical devices

Recall started
22 November 2021
Reason
Lower than expected results for VITROS¿ Immunodiagnostic Products TSH Reagent Pack when diluted with VITROS¿ Immunodiagnostic Products High Sample Diluent A Reagent Pack Lot 2190.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, DC, DE, FL, GA, IA, IL, IN, KY, LA, MD, ME, MI, MO, MS, MT, NC, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WI, WV and the countries of Australia, Brazil, Canada, Chile, China, Colombia, India, Japan
Initiated
Voluntary: Firm initiated
Recall number
Z-0503-2022

Terminated Class III Medical devices

Recall started
15 October 2021
Terminated
18 December 2023
Reason
Ortho Clinical Diagnostics confirmed a complaint that some VITROS Immunodiagnostic Products Anti-HBc IgM Controls Lot 1690 Controls Values booklet contained information for the incorrect product. While the accuracy of patient test results is not affected by this issue, there is a potential for delayed results due to the troubleshooting of Quality Control results.
Distribution
US (Domestic) distribution to states of: AZ, CA, CO, CT, FL, GA, LA, MA, MO, NJ, NY, OK, SC, SD, TX, UT, WA, WI, and WV. OUS (Foreign) distribution to Colombia.
Initiated
Voluntary: Firm initiated
Recall number
Z-0247-2022

Terminated Class II Medical devices

Recall started
3 May 2021
Terminated
24 October 2023
Reason
Ortho investigated and confirmed the potential for unexpected failed calibration, and condition codes associated with the calibration, when using VITROS SARS-CoV-2 Ag Reagent Pack along with VITROS Immunodiagnostic Products SARS-CoV-2 Ag Calibrator, Lot 20.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AR, CA, IA, IL, LA, MO, MS, TX, WI, and the countries of Colombia, India, Japan, Italy, Spain, Portugal, France.
Initiated
Voluntary: Firm initiated
Recall number
Z-1688-2021

Terminated Class II Medical devices

Recall started
26 March 2021
Terminated
24 May 2023
Reason
Delayed results. Ortho confirmed that two lots of VITROS Black Reference Slides are incorrectly labelled as White Reference Slides. If the customer fails to notice both the product name or the unexpected color of the slides and tries to use Black Reference Slides as White Reference Slides, the Correction Factor test will fail - and the analyzer will not be able to produce results for any assays other than sodium, potassium, and chloride. If the customer doesnt have any White Reference Slides in reserve, they cant run the Correction Factor test correctly and get the analyzer running again until they get more White Reference Slides delivered. This could lead to a delay in results for all Vitros assays except for sodium, potassium, and chloride.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AL, AR, CA, CO, CT, FL GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, ND, NE, NH, NJ, NY, OH, OK, PA, SC, TN, TX, VA, WA, WI, WV, WY and the countries of Australia, Bermuda, Brazil, Canada, China, Colombia, Ind
Initiated
Voluntary: Firm initiated
Recall number
Z-1489-2021

Terminated Class II Medical devices

Recall started
18 February 2021
Terminated
18 October 2022
Reason
Potential total iron-binding capacity (TIBC) results. The VITROS TIBC performance shift will start with the newest Generation (GEN) of VITROS Fe Slides (GEN 26), the potential shift in TIBC patient values of GEN 26 and above will be approximately 80 ug/dL lower across the measuring range than other available GENS of VITROS Fe Slides (GENs 22-25).
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Australia, Belgium, Brazil, Canada L3R 4G5, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Poland, Portugal, Russia, Singapore 609917, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-1295-2021

Terminated Class II Medical devices

Recall started
12 February 2021
Terminated
24 January 2022
Reason
VITROS Immunodiagnostic Products SARS-CoV-2 Antigen False Reactive Results Associated When Using Remel M4RT Viral Transport Media
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Australia, Belgium, Canada L3R 4G5, Chile, Colombia, Denmark, France, Germany, India, Italy, Japan, Portugal, Russia, Singapore 609917, Spain, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1267-2021, Z-1266-2021

Terminated Class II Medical devices

Recall started
14 January 2021
Terminated
27 December 2022
Reason
A deformity affecting a specific lot of VITROS¿ Chemistry Products VersaTips. Deformed VersaTips results may be biased by up to +/-16% for both immunometric and competitive assays.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, SC, TN, TX, VA, WA, WI and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1136-2021

Terminated Class II Medical devices

Recall started
20 November 2020
Terminated
24 October 2023
Reason
A software anomaly may cause an aliquoted sample to be labelled as the incorrect sample. This may lead to results being associated with the wrong patient sample and potentially lead to inappropriate intervention with the potential for injury to the patient.
Distribution
Worldwide distribution - US Nationwide distribution including the states of CA, CO, MA, MD, NC, OH, TX, VA, VT, and Belgium, Bermuda, Canada, China, France, Italy, Japan, Mexico, Norway, Portugal, Singapore, Spain, Sweden, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0800-2021, Z-0801-2021

Terminated Class II Medical devices

Recall started
13 July 2020
Terminated
27 July 2021
Reason
Etrombopag Interference for VITROS Chemistry Products: TBIL Slides, VITROS BuBc Slides and VITROS XT TBIL-ALKP Slides
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Australia, Belgium, Bermuda HM08, Brazil, Canada L3R 4G5, China, Denmark, France, Germany, Italy, Mexico, Norway, Poland, Portugal, Russia, Singapore 609917, Spain, Sweden, The Netherlands, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2875-2020, Z-2873-2020, Z-2874-2020

Terminated Class II Medical devices

Recall started
11 May 2020
Terminated
22 September 2021
Reason
Multiple coatings of VITROS Chemistry Products AMYL Slides are showing imprecision on control fluids when compared to the expected within lab SD as listed on the Performance Verifier (PV) Assay Sheets.
Distribution
Worldwide distribution - US Nationwide including in the statesof Maine, Massachusetts, Vermont, Connecticut, New Jersey, New York, Pennsylvania, Washington DC, Maryland, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Alabama, Tennessee, Missouri, Mississippi, Kentucky, Oh
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2366-2020, Z-2364-2020, Z-2367-2020, Z-2365-2020

Terminated Class II Medical devices

Recall started
1 April 2020
Terminated
19 January 2021
Reason
The Spanish and Swedish language versions of the IFU state that the assay can be tested with Plasma which is false and could result in biased results.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1931-2020, Z-1930-2020

Terminated Class II Medical devices

Recall started
10 September 2019
Terminated
13 November 2020
Reason
Users may experience intermittent slide dispense issues with some cartridges due to the anti-backup platen failing to advance inside the cartridge.
Distribution
Domestic distribution nationwide. Foreign distribution to Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, the Netherlands, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0268-2020, Z-0269-2020, Z-0267-2020

Terminated Class II Medical devices

Recall started
17 June 2019
Terminated
9 November 2020
Reason
Potentially Biased Results using VITROS Chemistry Products GLU Slides
Distribution
US Nationwide Distribution - AL, AR, CA, CO, CT, FL, KS, KY, MA, MN, TN
Initiated
Voluntary: Firm initiated
Recall number
Z-2202-2019

Terminated Class II Medical devices

Recall started
8 April 2019
Terminated
12 November 2020
Reason
Potential negative drift in Creatine Kinase (CK) results when used on the VITROS 250 and 350 Systems.
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1936-2019, Z-1933-2019, Z-1935-2019, Z-1934-2019

Terminated Class II Medical devices

Recall started
20 March 2019
Terminated
8 December 2020
Reason
Potential for sample fluid to be dispensed to an incorrect position on the MicroSlide, potentially leading to erroneous assay results being reported
Distribution
Worldwide Distribution - US Nationwide in the states of AZ, CA, IL, OH, FL, TX, MI Foreign: Australia, Belgium, Chile, India, Italy, Japan, South Korea, Spain, Canada,, Phillippines
Initiated
Voluntary: Firm initiated
Recall number
Z-1364-2019

Terminated Class II Medical devices

Recall started
11 March 2019
Terminated
7 December 2020
Reason
One of the software algorithms used to detect sample dispense errors was inadvertently disabled. Because of this, sample dispense errors may lead to incorrect results being reported without an error code to alert the user.
Distribution
Worldwide Distribution - US Nationwide in the states of: AZ, CA, FL, IL, OH, TX, and VA. The products were distributed to the following foreign countries: Australia, Belgium, Canada, Chile, Columbia, France, India, Italy, Japan, Portugal, Singapore, Spain, United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-1222-2019

Terminated Class II Medical devices

Recall started
20 February 2019
Terminated
15 September 2021
Reason
Luminometer Malfunction May Cause Inability to Process MicroWell Assays on VITROS¿ Systems
Distribution
Worldwide Distribution: US (Nationwide) and countries of: Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden,The Netherlands, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1289-2019, Z-1292-2019, Z-1287-2019, Z-1288-2019, Z-1293-2019, Z-1291-2019, Z-1290-2019

Terminated Class II Medical devices

Recall started
22 January 2019
Terminated
10 June 2022
Reason
Imprecision in the affected lot may produce negatively or positively biased patient sample and quality control fluid results.
Distribution
US Distribution to states of: AL, CA, CT, FL, HI, IA, ID, IL, LA, MI, MO, MS, NC, NM, NY, OK, PA, TX, WV, and WY; and internationally to: Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0992-2019

Terminated Class II Medical devices

Recall started
11 December 2018
Terminated
16 September 2020
Reason
Negative bias results when using VITROS VALP Reagent, GEN 25.
Distribution
Worldwide distribution- US (Nationwide) and countries of: Australia, Belgium, Bermuda, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-0848-2019

Ongoing Class II Medical devices

Recall started
1 November 2018
Reason
The firm is extending their previous July 2018 recall to include additional product codes. Biased results may occur for these additional products at biotin concentrations which are lower than indicated in the current Instructions for Use.
Distribution
Worldwide Distribution - US Nationwide domestic distribution. International distribution to Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, India, France, Japan, Germany, Italy, Mexico, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, and Uni
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0689-2019, Z-0687-2019, Z-0688-2019

Terminated Class II Medical devices

Recall started
19 October 2018
Terminated
24 January 2022
Reason
Software anomaly may incorrectly extend the on-analyzer stability time for a loaded VITROS Reagent.
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0651-2019, Z-0652-2019, Z-0653-2019, Z-0650-2019

Terminated Class II Medical devices

Recall started
8 October 2018
Terminated
13 October 2022
Reason
VITROS Chemistry Products dLDL Reagent GENs 26 and 27, negatively biased results
Distribution
Nationwide Foreign: Australia Belgium Bermuda, HM11 Brazil Canada L3R 4G5 Chile China Colombia Denmark France Germany India Italy Japan Mexico Norway Poland Portugal Russia Singapore Spain Sweden The Netherlands United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-0476-2019

Terminated Class II Medical devices

Recall started
28 August 2018
Terminated
11 August 2020
Reason
The reagent pack exhibits the potential for an increased frequency of calibration failures.
Distribution
Worldwide Distribution: US (nationwide) to the following US states: AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, PA, SC, SD, TN, TX, VT, WA, WI, WV, and WY; and countries of: Belgium, Bermuda, Brazil, Canada, Chile, Columb
Initiated
Voluntary: Firm initiated
Recall number
Z-0392-2019

Terminated Class II Medical devices

Recall started
15 August 2018
Terminated
10 January 2022
Reason
Potential for the VITROS 5600 Integrated System to dispense an insufficient sample volume onto a MicroSlide without suppressing the potentially incorrect result.
Distribution
Nationwide Foreign: France, Brazil, Chile, Great Britain, Phillippines, Spain
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0080-2019, Z-0079-2019

Terminated Class III Medical devices

Recall started
11 July 2018
Terminated
11 August 2020
Reason
The slides do not meet the maximum allowable interference (MAI) claims for triglyceride interference when using serum samples. Triglyceride interference on the Cl- Slide was observed around a triglyceride concentration 600mg/dL, however the current triglyceride interference claim states interference should not occur below 800mg/dL of triglyceride.
Distribution
Worldwide Distribution - US Nationwide and in the countries of: Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3043-2018, Z-3044-2018

Terminated Class III Medical devices

Recall started
11 July 2018
Terminated
19 August 2020
Reason
The slides did not meet the current claims for Limit of Blank (LoB), Limit of Detection (LoD) and Limit of Quantification (LoQ) for serum and urine samples and therefore affecting the low end of the measuring range for this assay. The current low end measuring range is 0.05mg/dL for serum and 1.2mg/dL for urine. Based on the CREA testing results for the LoQ, the revised low end CREA measuring range is 0.15mg/dL for serum and 3.2mg/dL for urine.
Distribution
Worldwide distribution. US nationwide, Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-3193-2018

Terminated Class III Medical devices

Recall started
11 July 2018
Terminated
11 August 2020
Reason
The slides failed to meet current claims for Limit of Blank (LoB), Limit of Detection (LoD) and Limit of Quantification (LoQ) for urine samples. The measuring range (15-300 mmol/L) for urine samples when tested with the Cl- slide is not affected. The current Cl- LoQ is 5 mmol/L and the LoQ determined by this investigation is 15 mmol/L.
Distribution
Worldwide Distribution - US Nationwide- The products were distributed to the following foreign countries: Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Poland, Portugal, Russia, Singapore, Spain, Sweden, The Nether
Initiated
Voluntary: Firm initiated
Recall number
Z-3184-2018

Terminated Class II Medical devices

Recall started
9 May 2018
Terminated
18 August 2020
Reason
There is a potential for imprecise results when using the slides. Increase in imprecision when using PHYT coating 0165. This leads to higher and lower than expected results for both quality control samples and patient samples.
Distribution
Worldwide distribution. US nationwide, Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Singapore, Spain, and Sweden
Initiated
Voluntary: Firm initiated
Recall number
Z-2344-2018

Terminated Class II Medical devices

Recall started
5 May 2018
Terminated
19 February 2021
Reason
Potential for positively biased results
Distribution
US Nationwide, Bermuda, Austria, Brazil, Canada, Colombia, China, India, Japan, Mexico, Singapore, UK, France, Germany, Italy, Spain, Portugal, Poland, Russia, Denmark, Norway, Sweden, Belgium and the Netherlands
Initiated
Voluntary: Firm initiated
Recall number
Z-3280-2018

Terminated Class II Medical devices

Recall started
22 September 2017
Terminated
24 August 2020
Reason
This product is not meeting the current storage labeling for unopened VITROS DAT Performance Verifiers causing customers to obtain lower than expected VITROS BENZ results when using this control.
Distribution
Worldwide distribution: US Nationwide (including Puerto Rico), Bermuda, Australia, Brazil, Canada, Chile, Colombia, India, Japan, Mexico, Panama, Singapore, Venezuela, England, France, Germany, Italy, Spain, Poland, and Russia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0914-2018, Z-0915-2018, Z-0912-2018, Z-0913-2018, Z-0911-2018

Terminated Class II Medical devices

Recall started
12 June 2017
Terminated
11 August 2020
Reason
The firm identified the potential for biased results to be generated when processing VITROS PHYT Slide product with citrate plasma specimen samples. The current Instructions for Use (IFU) and Assay Summary Chart state serum, heparin plasma, and citrate plasma as acceptable specimen types for use with the PHYT assay.
Distribution
Worldwide Distribution - US Distribution including Puerto Rico and the following countries: Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico, Republic of Panama, Poland, Singapore, Spain, Russia and Venezuela.
Initiated
Voluntary: Firm initiated
Recall number
Z-0273-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.